Release Therapeutics is thrilled to announce our participation in FutureHealth Lausanne 2024, which kicks off at the SwissTech Convention Center on 1 October 2024 and where we will be represented by Julien Grogg, PhD, MBA, our Chief Operating Officer!
We look forward to connecting with other innovators in the life sciences and to discussing our best-in-class technology for the treatment of genetic disorders of the CNS!
The Release Tx Team
Comments